Edition:
United States

People: C R Bard Inc (BCR)

BCR on New York Consolidated

242.41USD
17 Feb 2017
Change (% chg)

$0.62 (+0.26%)
Prev Close
$241.79
Open
$241.66
Day's High
$242.68
Day's Low
$240.15
Volume
782,477
Avg. Vol
571,520
52-wk High
$242.68
52-wk Low
$185.72

Holland, Christopher 

Mr. Christopher S. Holland is Chief Financial Officer, Senior Vice President of the Company. He joined Bard in 2012 as Senior Vice President and Chief Financial Officer. In July 2013, Mr. Holland assumed additional responsibilities for Bard Medical Division. Prior to joining Bard, he held executive positions at ARAMARK Corporation since 2003 and was most recently Senior Vice President, Finance and Treasurer. Previously, Mr. Holland held various positions at J.P. Morgan and Company, Inc., including Vice President, with responsibility for the medical device sector.

Basic Compensation

Total Annual Compensation, USD 611,091
Restricted Stock Awards, USD 1,324,810
Long-Term Incentive Plans, USD --
All Other, USD 1,716,640
Fiscal Year Total, USD 3,652,540

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Timothy Ring

11,744,800

John Weiland

6,920,670

James Beasley

3,827,980

Timothy Collins

3,909,070

John Groetelaars

--

Christopher Holland

3,652,540
As Of  30 Dec 2015